Financial information

The information source is the annual report of the company with business id 556713-3425

* Closing information (×1000) SEK

Fiscal year 202403 202303 (consolidated) 202203 (consolidated)
Number of months: 12 12
Turnover: 264,168 Revenue Up 259,913 Revenue Down 409,753
Financial expenses: 5,732 Revenue Up 2,372 Revenue Down 2,874
Earnings before taxes: 28,604 Revenue Down 38,968 Revenue Up 35,965
Total assets: 373,759 Revenue Up 285,696 Revenue Up 237,888
Current assets: 197,774 Revenue Up 167,228 Revenue Up 123,452
Current liabilities: 162,050 Revenue Up 115,976 Revenue Up 98,757
Equity capital: 177,726 Revenue Up 154,753 Revenue Up 123,626
Share capital: 1,308 1,308 1,308
Number of employees: 21 Revenue Up 18 Revenue Up 13

Financial ratios

Solvency: 47.6% Revenue Down 54.2% Revenue Up 52.0%
Turnover per employee: 12,579 Revenue Down 14,440 Revenue Down 31,519
Profitability: 10.8% Revenue Down 15.0% Revenue Up 8.8%
Return on equity (ROE): 16.1% Revenue Down 25.2% Revenue Down 29.1%
Current ratio: 122.0% Revenue Down 144.2% Revenue Up 125.0%
Return on assets (ROA): 9.2% Revenue Down 14.5% Revenue Down 16.3%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202403
Number of months: 12
Turnover: 264,168
Financial expenses: 5,732
Earnings before taxes: 28,604
Total assets: 373,759
Current assets: 197,774
Current liabilities: 162,050
Equity capital: 177,726
Share capital: 1,308
Number of employees: 21

Financial ratios

Solvency: 47.6%
Turnover per employee: 12,579
Profitability: 10.8%
Return on equity (ROE): 16.1%
Current ratio: 122.0%
Return on assets (ROA): 9.2%